BioPharmaFocus on the pharmaceutical and biotech industry
- Jeremy Levin: Challenges of Working with Rare Diseases
Jeremy Levin, Chairman and Chief Executive Officer of Ovid Therapeutics, discusses the challenges of a small biotech company working with rare diseases, especially rare neurological disorders.
- Albiero Pharma Overview and Focus on Rare Pediatric Liver Diseases
Ron Cooper, President and CEO of Albireo, discusses his company and lead product. Albireo is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders.
- Focus on Cystinosis
Mr. Robert (Bob) E. Ward, Chairman of the Board and Chief Executive Officer of Eloxx Pharmaceuticals provides an overview of Cystinosis, an inherited condition in which the body accumulates the amino acid cystine (a building block of proteins) within the cells.
- ArQule Overview and Focus on Rare Diseases
Brian Schwartz, Chief Medical Officer of ArQule, discusses his company and it’s focus on disease management. ArQule is engaged in the research and development of targeted therapeutics to treat cancers and certain rare diseases.
- Alnylam Overview
Barry Greene, President of Alnylam, joined the company in 2003 and has more than 25 years of experience in healthcare, pharmaceutical, and biotechnology industries.
- Interecept Pharma: Focused on Non-Viral Liver Diseases
Gail Cawkwell, MD, PhD, Senior Vice President, Medical Affairs at Intercept, provides an overview of the company.
- Corbus Pharmaceuticals Corporate Overview
Yuval Cohen, PhD, CEO of Corbus Pharmaceuticals discusses his company’s growth over the past few years and provided an overview of Lenabasum, a novel, oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes.
- Baebies: Newborn Screening Platforms
Richard West, Founder and CEO of Baebies, a newborn testing diagnostic company. In this video, Mr West discusses the company’s two main platforms.
- ArQule’s Focus on Rare Diseases
Brian Schwartz, Chief Medical Officer of ArQule, discusses his company and it’s focus on disease management.
- Participating at the BIO Convention
Yuval Cohen, PhD, CEO of Corbus Pharmaceuticals discusses the importance of his company’s support for the BIO International Convention.